Concordance between plasma-based and tissue-based next-generation sequencing in LOTUS

Lancet Oncol. 2017 Nov;18(11):e638. doi: 10.1016/S1470-2045(17)30785-4. Epub 2017 Oct 31.

Authors

Sung-Bae Kim¹, Rebecca Dent², Matthew J Wongchenko³, Stina M Singel³, José Baselga⁴; LOTUS investigators

Affiliations

¹ Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: sbkim3@amc.seoul.kr.
² Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
³ Genentech Inc, South San Francisco, CA 94080, USA.
⁴ Memorial Sloan Kettering Cancer Center, New York, NY, USA.

PMID: 29208392
DOI: 10.1016/S1470-2045(17)30785-4

No abstract available

Publication types

Letter
Comment

MeSH terms

High-Throughput Nucleotide Sequencing*
Mutation*